Free Trial

NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History

NeuroBo Pharmaceuticals logo
$1.58 +0.03 (+1.94%)
As of 03/24/2025

NeuroBo Pharmaceuticals Stock Price Performance

5 Day
Performance
-0.58%
1 Month
Performance
+1.28%
3 Month
Performance
-2.47%
6 Month
Performance
-52.41%
Year-To-Date
Performance
-20.20%
1 Year
Performance
-63.97%
Receive NRBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRBO Stock Chart for Tuesday, March, 25, 2025

Remove Ads

NeuroBo Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
03/24/2025$1.55$1.55$1.56$1.5111,983 shs$13.36 million
03/21/2025$1.59$1.55
-2.47%
$1.59$1.4833,721 shs$13.36 million
03/20/2025$1.57$1.59
+1.22%
$1.62$1.5213,674 shs$13.69 million
03/19/2025$1.59$1.57
-1.26%
$1.62$1.508,745 shs$13.53 million
03/18/2025$1.48$1.59
+7.44%
$1.64$1.4827,121 shs$13.70 million
03/17/2025$1.48$1.48$1.54$1.4522,374 shs$12.75 million
03/14/2025$1.46$1.51
+3.08%
$1.56$1.496,636 shs$12.97 million
03/13/2025$1.46$1.46$1.55$1.4511,580 shs$12.58 million
03/12/2025$1.48$1.46
-1.35%
$1.55$1.4511,580 shs$12.58 million
03/11/2025$1.55$1.48
-4.52%
$1.66$1.4333,642 shs$12.75 million
03/10/2025$1.55$1.55$1.68$1.4351,792 shs$13.36 million
03/07/2025$1.52$1.57
+3.29%
$1.60$1.538,112 shs$13.53 million
03/06/2025$1.46$1.52
+4.11%
$1.59$1.4217,458 shs$13.10 million
03/05/2025$1.46$1.46$1.50$1.4121,264 shs$12.58 million
03/04/2025$1.46$1.46$1.50$1.4121,264 shs$12.58 million
03/03/2025$1.46$1.46$1.50$1.4121,264 shs$12.58 million
02/28/2025$1.51$1.46
-3.31%
$1.59$1.2937,613 shs$12.58 million
02/27/2025$1.57$1.51
-4.07%
$1.65$1.2951,517 shs$13.01 million
02/26/2025$1.56$1.57
+0.90%
$1.64$1.5723,217 shs$13.56 million
02/25/2025$1.60$1.56
-2.73%
$1.67$1.5612,670 shs$13.44 million
02/24/2025$1.60$1.60$1.70$1.5519,514 shs$13.82 million

This page (NASDAQ:NRBO) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners